Grant Richard N. Jr. 4
Research Summary
AI-generated summary
InTest (INTT) CEO Richard Grant Sells 1,636 Shares
What Happened
Richard N. Grant Jr., President, CEO and Director of InTest Corporation, reported a small open‑market sale and several grant transactions. On 2026-03-18 he sold 1,636 shares at a weighted average price of $14.28 for proceeds of $23,360. On 2026-03-16 he was granted restricted/derivative awards totaling 51,009 shares (two grants of 13,822 shares and one 23,365-share award) at $0.00 per share as compensation under the InTest 2023 Stock Incentive Plan.
Key Details
- Sale: 2026-03-18 — 1,636 shares disposed; weighted average price reported $14.28 (sales executed in multiple trades at $14.25–$14.425). Total cash received ~ $23,360. (Footnotes F3, F4)
- Grants: 2026-03-16 — grants reported as acquired at $0.00 (total shown = 51,009 shares). Some grants are time-based and some performance‑based. (Footnotes F1, F2)
- Vesting: Time-based restricted shares vest in four equal annual installments beginning March 16, 2027 (F1). Performance-based restricted shares vest in March 2029 subject to performance criteria; the filing shows target amounts and notes a maximum that may vest. (F2)
- Sale reason and mechanics: The shares sold were to satisfy tax withholding in connection with vesting and were effected under a Rule 10b5-1 trading plan adopted Dec 8, 2023 (F3). The filer offers to provide per‑price breakdown on request (F4).
- Options/other notes: The filing includes footnotes about option vesting schedules (F5–F9) though no option exercise or option proceeds are listed in these transactions.
- Shares owned after transaction: Not specified in the supplied transaction summary / Form 4 excerpt.
- Timeliness: Form 4 filed 2026-03-18 for transactions on 2026-03-16–03-18; no late filing flag indicated.
Context
The March 18 sale appears to be a routine tax‑withholding sale carried out under a pre-established 10b5‑1 plan, which is common when restricted stock vests and does not necessarily signal the insider’s market view. The March 16 entries are compensation grants (time‑based and performance‑based) that will vest later if time and/or performance conditions are met; such awards are standard executive compensation.